| Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease JP Hugot, M Chamaillard, H Zouali, S Lesage, JP Cézard, J Belaiche, ... Nature 411 (6837), 599-603, 2001 | 7170 | 2001 |
| 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management F Gomollón, A Dignass, V Annese, H Tilg, G Van Assche, JO Lindsay, ... Journal of Crohn's and Colitis 11 (1), 3-25, 2017 | 2386 | 2017 |
| CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease S Lesage, H Zouali, JP Cézard, JF Colombel, J Belaiche, S Almer, C Tysk, ... The American Journal of Human Genetics 70 (4), 845-857, 2002 | 1234 | 2002 |
| Hepatic and extrahepatic malignancies in primary sclerosing cholangitis A Bergquist, A Ekbom, R Olsson, D Kornfeldt, L Lööf, Å Danielsson, ... Journal of hepatology 36 (3), 321-327, 2002 | 879 | 2002 |
| East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort J Burisch, N Pedersen, S Čuković-Čavka, M Brinar, I Kaimakliotis, ... Gut 63 (4), 588-597, 2014 | 601 | 2014 |
| Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ... Gastroenterology 152 (8), 1975-1984. e8, 2017 | 532 | 2017 |
| Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives M Elmberg, R Hultcrantz, A Ekbom, L Brandt, S Olsson, R Olsson, ... Gastroenterology 125 (6), 1733-1741, 2003 | 367 | 2003 |
| The AST/ALT ratio as an indicator of cirrhosis in patients with PBC H Nyblom, E Björnsson, M Simrén, F Aldenborg, S Almer, R Olsson Liver International 26 (7), 840-845, 2006 | 360 | 2006 |
| Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study M Werner, H Prytz, B Ohlsson, S Almer, E Björnsson, A Bergquist, ... Scandinavian journal of gastroenterology 43 (10), 1232-1240, 2008 | 317 | 2008 |
| The epidemiology and clinical features of portal vein thrombosis: a multicentre study R Rajani, E Björnsson, A Bergquist, Å Danielsson, A Gustavsson, O Grip, ... Alimentary pharmacology & therapeutics 32 (9), 1154-1162, 2010 | 241 | 2010 |
| Acute liver failure in Sweden: etiology and outcome G Wei, A Bergquist, U Broomé, S Lindgren, S Wallerstedt, S Almer, ... Journal of internal medicine 262 (3), 393-401, 2007 | 238 | 2007 |
| Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease Y Momozawa, M Mni, K Nakamura, W Coppieters, S Almer, L Amininejad, ... Nature genetics 43 (1), 43-47, 2011 | 227 | 2011 |
| Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease U Hindorf, M Lindqvist, H Hildebrand, U Fagerberg, S Almer Alimentary pharmacology & therapeutics 24 (2), 331-342, 2006 | 221 | 2006 |
| Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease U Hindorf, M Lindqvist, C Peterson, P Söderkvist, M Ström, H Hjortswang, ... Gut 55 (10), 1423-1431, 2006 | 216 | 2006 |
| Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis A Bergquist, SM Montgomery, S Bahmanyar, R Olsson, Å Danielsson, ... Clinical gastroenterology and hepatology 6 (8), 939-943, 2008 | 215 | 2008 |
| Budd‐Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival–an 18‐year experience R Rajani, T Melin, E Björnsson, U Broomé, P Sangfelt, Å Danielsson, ... Liver International 29 (2), 253-259, 2009 | 190 | 2009 |
| Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease S Levenstein, Z Li, S Almer, A Barbosa, P Marquis, G Moser, A Sperber, ... Official journal of the American College of Gastroenterology| ACG 96 (6 …, 2001 | 169 | 2001 |
| Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. E Peen, S Almer, G Bodemar, BO Ryden, C Sjölin, K Tejle, T Skogh Gut 34 (1), 56-62, 1993 | 168 | 1993 |
| The Short Health Scale: a valid measure of subjective health in ulcerative colitis H Hjortswang, G Järnerot, B Curman, H Sandberg-Gertzén, C Tysk, ... Scandinavian journal of gastroenterology 41 (10), 1196-1203, 2006 | 158 | 2006 |
| Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC) U Broomé, H Glaumann, E Lindstöm, L Lööf, S Almer, H Prytz, ... Journal of hepatology 36 (5), 586-589, 2002 | 157 | 2002 |
jean-pierre hugotUniversité de Paris在 aphp.fr 的电子邮件经过验证